ENDOCANNABINOID SYSTEM GENETICS-HUMAN

ABHD12 GENES (Cause Production of an Enzyme that Breaks Down 2-AG)
ATT / (ATT)n GENES +
CB1 GENES +
CB2 GENES +
COMT GENES +
CYP GENES (Production of Their Enzymes is Blocked by THC, CBD and CBN)
DAGL GENES
EPIGENETICS (Genes Being Turned Off, Or On, By Chemical Reactions)
FAAH GENES +
MAGL GENES
MISC GENETICS + (Other Genes That Affect the Endocannabinoid System)
RS GENES POLYMORPHISMS + (Various)


ABHD12 GENES
Mutations in ABHD12 Cause the Neurodegenerative Disease PHARC: An Inborn Error of Endocannabinoid Metabolism (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2933347/?tool=pubmed
Targeted next-generation sequencing identifies a homozygous nonsense mutation in ABHD12, the gene underlying PHARC, in a family clinically diagnosed with Usher syndrome type 3 (full – 2012) http://www.ojrd.com/content/7/1/59
ABHD12 controls brain lysophosphatidylserine pathways that are deregulated in a murine model of the neurodegenerative disease PHARC (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3557017/
Two Novel Mutations in ABHD12: Expansion of the Mutation Spectrum in PHARC and Assessment of Their Functional Effects (full–2013)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3855015/
Exome sequencing extends the phenotypic spectrum for ABHD12 mutations: from syndromic to nonsyndromic retinal degeneration (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24697911


ATT / (ATT)n GENES
Sweet taste and (AAT)12 repeat in the cannabinoid receptor gene in obese females (letter–2011) https://www.jstage.jst.go.jp/article/endocrj/58/4/58_K11E-093/_pdf
Association between a cannabinoid receptor gene (CNR1) polymorphism and cannabinoid-induced alterations of the auditory event-related P300 potential (abst–2011) http://tinyurl.com/za6w3ty
Association between a Genetic Variant of Type-1 Cannabinoid Receptor and Inflammatory Neurodegeneration in Multiple Sclerosis (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3877004/
Cannabinoid Receptor 1 Gene and Irritable Bowel Syndrome: Phenotype and Quantitative Traits (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3602676/
CNR1 variation is associated with the age at onset in Huntington disease (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23747361
Genetic polymorphism in pathogenesis of irritable bowel syndrome (full–2014) http://www.wjgnet.com/1007-9327/full/v20/i47/17693.htm
Association of cannabinoid type 1 receptor and fatty acid amide hydrolase genetic polymorphisms in Chinese patients with irritable bowel syndrome (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24444427
top


CB1 GENES
A common polymorphism in the cannabinoid receptor 1 (CNR1) gene is associated with antipsychotic-induced weight gain in Schizophrenia (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3055343/?tool=pubmed
A common CNR1 (cannabinoid receptor 1) haplotype attenuates the decrease in HDL cholesterol that typically accompanies weight gain (full–2010)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3013130/?tool=pubmed
Polymorphisms in the endocannabinoid receptor 1 in relation to fat mass distribution (full–2010) http://www.eje-online.org/content/163/3/407.full
The Cannabinoid 1 Receptor (CNR1) 1359 G/A Polymorphism Modulates Susceptibility to Ulcerative Colitis and the Phenotype in Crohn’s Disease (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2829088/?tool=pmcentrez
Inactivation of the cannabinoid receptor CB1 prevents leukocyte infiltration and experimental fibrosis (full–2010) http://onlinelibrary.wiley.com/doi/10.1002/art.27642/full
G1359A polymorphism of the cannabinoid receptor gene (CNR1) and clinical results of biliopancreatic diversion (link to PDF–2010) http://www.europeanreview.org/article/724
Endocannabinoids and Schizophrenia (link to PDF–2010) http://www.mdpi.com/1424-8247/3/10/3101
G1359A polymorphism in the cannabinoid receptor-1 gene is associated with metabolic syndrome in the Chinese Han population (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20851297
Differential signaling in human cannabinoid CB(1) receptors and their splice variants in autaptic hippocampal neurons (full–2011) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2011.01744.x/pdf
Cannabinoids and B cells: emerging targets for treating progressive multiple sclerosis (full-2011) http://msj.sagepub.com/content/17/3/259.long
Adipose tissue endocannabinoid system gene expression: depot differences and effects of diet and exercise (full–2011) http://www.lipidworld.com/content/10/1/194
Association of genetic variation in cannabinoid mechanisms and gastric motor functions and satiation in overweight and obesity (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3117918/
Roles of G1359A polymorphism of the cannabinoid receptor gene (CNR1) on weight loss and adipocytokines after a hypocaloric diet (full–2011)
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0212-16112011000200012&lng=en&nrm=iso
The association of the rs1049353 polymorphism of the CNR1 gene with hypoadiponectinemia (full–2011) http://www.rjme.ro/RJME/resources/files/520311791795.pdf
The highs and lows of cannabinoid receptor expression in disease: mechanisms and their therapeutic implications (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3141881/
top
The Endocannabinoid System as Pharmacological Target Derived from Its CNS Role in Energy Homeostasis and Reward. Applications in Eating Disorders and Addiction (link to PDF-2011) http://www.mdpi.com/1424-8247/4/8/1101
Cannabinoid receptor 1 gene polymorphism and irritable bowel syndrome in the Korean population: a hypothesis-generating study. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/20505532
G1359A polymorphism in the cannabinoid receptor-1 gene is associated with coronary artery disease in the Chinese Han population. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/22029183
Personalized medicine can pave the way for the safe use of CB₁ receptor antagonists (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21497918
Cannabinoid Receptor 1 (CNR1) 4895 C/T Genetic Polymorphism was Associated with Obesity in Japanese Men (full–2012) https://www.jstage.jst.go.jp/article/jat/19/8/19_12732/_pdf
Binding of a tritiated inverse agonist to cannabinoid CB1 receptors is increased in patients with schizophrenia (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3463751/
The dynamic nature of type 1 cannabinoid receptor (CB1) gene transcription (full-2012) http://onlinelibrary.wiley.com/enhanced/doi/10.1111/j.1476-5381.2012.02175.x/
Randomized pharmacodynamic and pharmacogenetic trial of dronabinol effects on colon transit in irritable bowel syndrome-diarrhea (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3775711/
Irritable Bowel Syndrome: Methods, Mechanisms, and Pathophysiology. Genetic epidemiology and pharmacogenetics in irritable bowel syndrome (full–2012) http://ajpgi.physiology.org/content/302/10/G1075
CNR1 genotype influences HDL-cholesterol response to change in dietary fat intake (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3342253/
Sensation-seeking genes and physical activity in youth (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3581711/
Cannabinoid Receptor Genotype Moderation of the Effects of Childhood Physical Abuse on Anhedonia and Depression (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3706194/
Failure to extinguish fear and genetic variability in the human cannabinoid receptor 1 (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3565211/
Cannabinoid Type 1 Receptor Gene Polymorphism and Macronutrient Intake (full–2012) http://www.karger.com/Article/FullText/343563
Childhood Obesity and the Role of Dopamine D2 Receptor and Cannabinoid Receptor-1 Gene Polymorphisms. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/23057570
The G1359A-CNR1 gene polymorphism is associated to glioma in Spanish patients (abst–2012) http://link.springer.com/article/10.1007%2Fs12094-010-0604-7#page-1
top
G1359A polymorphism in the cannabinoid receptor-1 gene is associated with the presence of coronary artery disease in patients with type 2 diabetes (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22138970
Genetic variability in the endocannabinoid system and 12-week clinical response to citalopram treatment: the role of the CNR1, CNR2 and FAAH genes (abst–2012) http://jop.sagepub.com/content/26/10/1391
Role of G1359A polymorphism of the cannabinoid receptor gene on weight loss and adipocytokines levels after two different hypocaloric diets (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/21543209
The genetic basis of the endocannabinoid system and drug addiction in humans (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/21937688
Genetic variability in the endocannabinoid system and 12-week clinical response to citalopram treatment: the role of the CNR1, CNR2 and FAAH genes (abst–2012) http://jop.sagepub.com/content/26/10/1391
‘Cannabis’ receptor discovery may help understanding of obesity and pain (news – 2012) http://phys.org/news/2012-08-cannabis-receptor-discovery-obesity-pain.html
Molecular basis for dramatic changes in cannabinoid CB1 G protein-coupled receptor activation upon single and double point mutations (full-2013) http://onlinelibrary.wiley.com/doi/10.1002/pro.2192/full
Activation-dependent plasticity of polarized GPCR distribution on the neuronal surface (full – 2013) http://jmcb.oxfordjournals.org/content/5/4/250.long
Novel Insights Into CB1 Cannabinoid Receptor Signaling: A Key Interaction Identified Between EC3-Loop and TMH2 (full–2013) http://jpet.aspetjournals.org/content/early/2013/02/21/jpet.112.201046.long
Moderation of antipsychotic-induced weight gain by energy balance gene variants in the RUPP autism network risperidone studies (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693401/
Cannabis, a complex plant: different compounds and different effects on individuals (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3736954/
Further evidence for association of polymorphisms in the CNR1 gene with cocaine addiction: confirmation in an independent sample and meta-analysis (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3223560/
Influence of G1359A polimorphysm of the cannabinoid receptor gene (CNR1) on insulin resistance and adipokines in patients with non alcoholic fatty liver disease (full–2013) http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0212-16112012000500039&lng=en&nrm=iso&tlng=en
Impulsivity, Variation in the Cannabinoid Receptor (CNR1) and Fatty Acid Amide Hydrolase (FAAH) Genes, and Marijuana-Related Problems (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817049/
Common polymorphism in the cannabinoid type 1 receptor gene (CNR1) is associated with microvascular complications in type 2 diabetes (full–2013) http://www.jdcjournal.com/article/S1056-8727%2813%2900199-2/fulltext
top
The role of cannabinoid 1 receptor expressing interneurons in behavior (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3946968/
Evidence for a Common Endocannabinoid-Related Pathomechanism in Autism Spectrum Disorders (link to full–2013) http://www.sciencedirect.com/science/article/pii/S0896627313003619
Evidence for the involvement of cannabinoid receptors’ polymorphisms in the pathophysiology of human diseases (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23293857
Role of Genetic Variation in the Cannabinoid Receptor Gene (CNR1) (G1359A Polymorphism) on Weight Loss and Cardiovascular Risk Factors After Liraglutide Treatment in Obese Patients With Diabetes Mellitus Type 2 (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24322329
Genetic variation in the cannabinoid receptor gene (CNR1) (G1359A polymorphism) and their influence on anthropometric parameters and metabolic parameters under a high monounsaturated vs. high polyunsaturated fat hypocaloric diets (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23337343
CNR1 Gene and Risk of the Metabolic Syndrome in Patients With Schizophrenia (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23422373
Screening genetic variability at the CNR1 gene in both major depression etiology and clinical response to citalopram treatment (abst–2013) http://link.springer.com/article/10.1007%2Fs00213-013-2995-y
Computationally-predicted CB1 cannabinoid receptor mutants show distinct patterns of salt-bridges that correlate with their level of constitutive activity reflected in G protein coupling levels, thermal stability, and ligand binding (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23408552
Interrogating Therapeutic Manipulation of the Endocannabinoid System in Human Colon (abst–2013) http://www.fasebj.org/cgi/content/meeting_abstract/26/1_MeetingAbstracts/1123.1?sid=eea722c0 -971c-4daa-8b8c-38c0c63c19ad
No association of endocannabinoid genes with bipolar disorder or lithium response in a Sardinian sample (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24126189
Performance in working memory and attentional control is associated with the rs2180619 SNP in the CNR1 gene (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24152087
A Link Between Autism and Cannabinoids (news–2013) http://www.the-scientist.com/?articles.view/articleNo/35088/title/A-Link-Between-Autism-andCannabinoids/
Genetic Variations in the Human Cannabinoid Receptor Gene Are Associated with Happiness (full–2014) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0093771
Cannabinoid receptor 1 gene polymorphisms and nonalcoholic Fatty liver disease in women with polycystic ovary syndrome and in healthy controls (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4127238/
Association of polymorphisms in the endocannabinoid system genes with myocardial infarction and plasma cholesterol levels (full–2014) http://biomed.papers.upol.cz/getrevsrc.php?identification=public&mag=bio&raid=825&type=fin&ver=3
top
CB1 receptor affects cortical plasticity and response to physiotherapy in multiple sclerosis (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4268035/
Genetic polymorphism in pathogenesis of irritable bowel syndrome (full–2014) http://www.wjgnet.com/1007-9327/full/v20/i47/17693.htm
Endocannabinoid Receptors Gene Expression in Morbidly Obese Women with Nonalcoholic Fatty Liver Disease (full–2014) http://www.hindawi.com/journals/bmri/2014/502542/
Genetic association analysis of CNR1 and CNR2 polymorphisms with schizophrenia in a Korean population (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25014618
Altered expression of the CB1 cannabinoid receptor in the triple transgenic mouse model of Alzheimer’s disease (abst–2014) http://iospress.metapress.com/content/j04j4362605u1464/?p=09c91830dc7947dbb9d2c0ee83a7e915&pi=5
Antipsychotic induced weight gain: genetics, epigenetics, and biomarkers reviewed (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25138234
Genetic variability in the human cannabinoid receptor 1 is associated with resting state EEG theta power in humans (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25116250
Consequences of early life stress on the expression of endocannabinoid-related genes in the rat brain (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25083571
Functional Genetic Variation of the Cannabinoid Receptor 1 and Cannabis use Interact on Prefrontal Connectivity and Related Working Memory Behavior (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25139064
Cannabinoid receptor gene polymorphisms and bone mineral density in Korean post-menopausal women (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25268406
Selected CNR1 polymorphisms and hyperandrogenemia as well as fat mass and fat distribution in women with polycystic ovary syndrome (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25093427
Mutations in the ‘DRY’ motif of the CB1 cannabinoid receptor result in biased receptor variants (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25510402
Role of CNR1 polymorphisms in moderating the effects of psychosocial adversity on impulsivity in adolescents (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24980155
Association study of CNR1, GAD1 and BDNF polymorphisms with male heroin dependence in the Dai population in Yunnan (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25252306
Extravirgin olive oil up-regulates CB1 tumor suppressor gene in human colon cancer cells and in rat colon via epigenetic mechanisms (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25533906
top
Regulation of cannabinoid receptor gene expression and endocannabinoid levels in lymphocyte subsets by interferon-β: a longitudinal study in multiple sclerosis patients (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/cei.12443/full
Lack of hypophagia in CB1 null mice is associated to decreased hypothalamic POMC and CART expression (full–2015) http://ijnp.oxfordjournals.org/content/early/2015/03/09/ijnp.pyv011.long
Lack of association of DRD3 and CNR1 polymorphisms with premenstrual dysphoric disorders (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4475771/
Diacylglycerol lipase α knockout mice demonstrate metabolic and behavioral phenotypes similar to those of cannabinoid receptor 1 knockout mice (full–2015) http://journal.frontiersin.org/article/10.3389/fendo.2015.00086/full
Effects of a High-Protein/Low-Carbohydrate versus a Standard Hypocaloric Diet on Weight and Cardiovascular Risk Factors during 9 Months: Role of a Genetic Variation in the Cannabinoid Receptor Gene (CNR1) (G1359A Polymorphism) (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25766592
Association of G1359A polymorphism of the cannabinoid receptor gene (CNR1) with macronutrient intakes in obese females (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25664923
Polymorphism G1359A of the cannabinoid receptor gene (CNR1): allelic frequencies and influence on cardiovascular risk factors in a multicentre study of Castilla-Leon (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25682784
Epigenetic and Proteomic Expression Changes Promoted by Eating Addictive-like Behavior (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25944409
Endocannabinoid and ceramide levels are altered in patients with colorectal cancer (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25975960
Role of the endocannabinoid system in the emotional manifestations of osteoarthritis pain (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26067584
Brain structural and clinical changes after first episode psychosis: Focus on cannabinoid receptor 1 polymorphisms (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26071625
Elucidating Cannabinoid Biology in Zebrafish (Danio rerio) (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26192460
Dietary DHA reduced downstream endocannabinoid and inflammatory gene expression, epididymal fat mass, and improved aspects of glucose use in muscle in C57BL/6J mice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26219414
Pharmacogenetics in irritable bowel syndrome (full–2015) http://informahealthcare.com/doi/pdf/10.1517/17425255.2015.1048223
top


CB2 GENES
A nonsynonymous polymorphism in cannabinoid CB2 receptor gene is associated with eating disorders in humans and food intake is modified in mice by its ligands (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/19768813
CNR2 functional variant (Q63R) influences childhood immune thrombocytopenic purpura (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3232275/
Deletion of CB2 Cannabinoid Receptor Induces Schizophrenia-Related Behaviors in Mice (full–2011) http://www.nature.com/npp/journal/v36/n7/full/npp201134a.html
The highs and lows of cannabinoid receptor expression in disease: mechanisms and their therapeutic implications (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3141881/
Genetic association between bipolar disorder and 524A>C (Leu133Ile) polymorphism of CNR2 gene, encoding for CB2 cannabinoid receptor (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21658778
Cannabinoid receptor type 2 functional variant influences liver damage in children with non-alcoholic Fatty liver disease (full–2012) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0042259
Genetic variability in the endocannabinoid system and 12-week clinical response to citalopram treatment: the role of the CNR1, CNR2 and FAAH genes (abst–2012) http://jop.sagepub.com/content/26/10/1391
Impact of reference gene selection for type 2 cannabinoid receptor gene expression studies in human spermatozoa (abst–2012) http://onlinelibrary.wiley.com/doi/10.1111/and.12006/abstract
The Cannabinoid Receptor type 2 Q63R variant increases the risk of celiac disease: Implication for a novel molecular biomarker and future therapeutic intervention (abst–2012) http://www.sciencedirect.com/science/article/pii/S1043661812000540
Impact of reference gene selection for type 2 cannabinoid receptor gene expression studies in human spermatozoa (abst–2012) http://onlinelibrary.wiley.com/doi/10.1111/and.12006/abstract
Cannabis, a complex plant: different compounds and different effects on individuals (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3736954/
Childhood immune thrombocytopenia-who will spontaneously recover? (full–2013) http://www.seminhematol.org/article/S0037-1963%2813%2900032-2/fulltext
Differential expression and functional role of cannabinoid genes in alcohol users (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3818789/
Polymorphism rs3123554 in CNR2 reveals gender-specific effects on body weight and affects loss of body weight and cerebral insulin action (full–2013) http://onlinelibrary.wiley.com/doi/10.1002/oby.20573/full
top
Association Between a Polymorphism in Cannabinoid Receptor 2 and Severe Necro-inflammation in Patients With Chronic Hepatitis C (full–2013)
http://www.cghjournal.org/article/S1542-3565%2813%2900687-3/fulltext
Evidence for the involvement of cannabinoid receptors’ polymorphisms in the pathophysiology of human diseases (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23293857
Cannabinoid CB2 receptor gene (CNR2) polymorphism is associated with chronic childhood immune thrombocytopenia in Egypt (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23406660
Interrogating Therapeutic Manipulation of the Endocannabinoid System in Human Colon (abst–2013) http://www.fasebj.org/cgi/content/meeting_abstract/26/1_MeetingAbstracts/1123.1?sid=eea722c0 -971c-4daa-8b8c-38c0c63c19ad
Association of Single-Nucleotide Polymorphisms in the Cannabinoid Receptor 2 Gene with Schizophrenia in the Han Chinese Population (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23846977
Endocannabinoid Receptors Gene Expression in Morbidly Obese Women with Nonalcoholic Fatty Liver Disease (full – 2014) http://www.hindawi.com/journals/bmri/2014/502542/
Cannabinoid Receptor 2-63 QQ Variant Is Associated with Persistently Normal Aminotransferase Serum Levels in Chronic Hepatitis C. (full-2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4062424/
Cannabinoid Receptor 2-63 QQ Variant Is Associated with Persistently Normal Aminotransferase Serum Levels in Chronic Hepatitis C (full-2014) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0099450
The in vitro GcMAF effects on endocannabinoid system transcriptionomics, receptor formation, and cell activity of autism-derived macrophages (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996516/
Genetic polymorphism in pathogenesis of irritable bowel syndrome (full–2014) http://www.wjgnet.com/1007-9327/full/v20/i47/17693.htm
Examining the critical roles of human CB2 receptor residues Valine 3.32 (113) and Leucine 5.41 (192) in ligand recognition and downstream signaling activities (full–2014) http://www.sciencedirect.com/science/article/pii/S0006291X14014636
Synthetic marijuana “K2” induced ITP (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24749892
Genetic association analysis of CNR1 and CNR2 polymorphisms with schizophrenia in a Korean population (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25014618
Consequences of early life stress on the expression of endocannabinoid-related genes in the rat brain (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25083571
Species Differences in Cannabinoid Receptor 2 and Receptor Responses to Cocaine SelfAdministration in Mice and Rats (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25374096
Genetic background modifies the effects of type 2 cannabinoid receptor deficiency on bone mass and bone turnover (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24036631
top
Regulation of cannabinoid receptor gene expression and endocannabinoid levels in lymphocyte subsets by interferon-β: a longitudinal study in multiple sclerosis patients (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/cei.12443/full
No association between the functional cannabinoid receptor type 2 Q63R variants and inflammatory bowel disease in Turkish subjects (full–2015) http://www.turkjgastroenterol.org/sayilar/281/buyuk/639-43.pdf
The impact of the CB2-63 polymorphism on the histological presentation of chronic hepatitis B. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25749560
Osseous Characteristics of Mice Lacking Cannabinoid Receptor 2 after Pulp Exposure (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25773059
Association between cannabinoid receptor type 2 Q63R variant and oligo / polyarticular juvenile idiopathic arthritis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25974389
Over-expression of cannabinoid receptor 2 induces the apoptosis of cervical carcinoma Caski cells (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26062417
Role of the endocannabinoid system in the emotional manifestations of osteoarthritis pain (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26067584
Whole-cell biosensor for label-free detection of GPCR-mediated drug responses in personal cell lines. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/26143464
Elucidating Cannabinoid Biology in Zebrafish (Danio rerio) (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26192460
Association between cannabinoid receptor type 2 Q63R variant and oligo/polyarticular juvenile idiopathic arthritis (abst–2015) http://informahealthcare.com/doi/abs/10.3109/03009742.2015.1020863


COMT GENES
Molecular mechanisms underlying anorexia nervosa: focus on human gene association studies and systems controlling food intake (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/19931559
Cannabis, COMT and psychotic experiences (full–2011) http://bjp.rcpsych.org/content/199/5/380.long
COMT; another “wrong” result for the reefer madness hype (news–2011) http://ukcia.org/wordpress/?p=924
COMT val158met and 5-HTTLPR genetic polymorphisms moderate executive control in cannabis users (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3682154/
Psychosis-inducing effects of cannabis are related to both childhood abuse and COMT genotypes (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/acps.12108/full
top
What does a mouse tell us about neuregulin 1-cannabis interactions? (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3581817/


CYP GENES
Effects of a Commonly Occurring Genetic Polymorphism of Human CYP3A4 (I118V) on the Metabolism of Anandamide (full–2010) http://dmd.aspetjournals.org/content/38/11/2075.full
Characterization of major phytocannabinoids, cannabidiol and cannabinol, as isoformselective and potent inhibitors of human CYP1 enzymes (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20117100
Cannabidiol, a major phytocannabinoid, as a potent atypical inhibitor for CYP2D6 (full–2011) http://dmd.aspetjournals.org/content/39/11/2049.full.pdf+html
Genome-wide association study of antibody response to smallpox vaccine (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3367131/
Polymorphic expression of CYP2C19 and CYP2D6 in the developing and adult human brain causing variability in cognition, risk for depression and suicide: the search for the endogenous substrates (full–2014) http://www.futuremedicine.com/doi/full/10.2217/pgs.14.151
Functional consequences of synthetic cannabinoid metabolites and CYP2C9 polymorphisms (abst–2014) http://www.fasebj.org/content/28/1_Supplement/838.4.abstract?sid=467bb529-0ecc-4ddc-af27-3f56f520a102


DAGL GENES
Genetic Disruption of 2-Arachidonoylglycerol Synthesis Reveals a Key Role for Endocannabinoid Signaling in Anxiety Modulation (full–2014) http://www.cell.com/cell-reports/abstract/S2211-1247%2814%2900955-3?_returnURL=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS2211124714009553%3Fshowall%3Dtrue
Diacylglycerol lipase α knockout mice demonstrate metabolic and behavioral phenotypes similar to those of cannabinoid receptor 1 knockout mice (full – 2015) http://journal.frontiersin.org/article/10.3389/fendo.2015.00086/full
Anxiety, Stress, and Fear Response in Mice with Reduced Endocannabinoid Levels (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25981172
Fever Is Mediated by Conversion of Endocannabinoid 2-Arachidonoylglycerol to Prostaglandin E2 (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26196692
top


EPIGENETICS
Expression and functions of μ-opioid receptors and cannabinoid receptors type 1 in T lymphocytes (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22823387
Regulation of opioid and cannabinoid receptor genes in human neuroblastoma and T cells by the epigenetic modifiers trichostatin A and 5-aza-2′-deoxycytidine (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22262103
Reduced expression of brain cannabinoid receptor 1 (Cnr1) is coupled with an increased complementary micro-RNA (miR-26b) in a mouse model of fetal alcohol spectrum disorders (full–2013) http://www.clinicalepigeneticsjournal.com/content/5/1/14
Epigenetic mechanisms and endocannabinoid signaling (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/febs.12125/pdf
Low 17beta-Estradiol Levels in Cnr1 Knock-Out Mice Affect Spermatid Chromatin Remodeling by Interfering with Chromatin Reorganization (full–2013) http://www.biolreprod.org/content/88/6/152.long
Epigenetic Control of Skin Differentiation Genes by Phytocannabinoids (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3791996/
Epigenetics, drugs of abuse, and the retroviral promoter (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3878082/
New Study: THC May Treat Inflammatory Diseases and Cancer By Altering Genes (news–2013) http://thejointblog.com/new-study-thc-may-treat-inflammatory-diseases-cancer-altering-genes/
Scientists Believe THC May Offer New Form Of Gene Therapy (news–2013) http://www.leafscience.com/2013/11/24/scientists-believe-thc-may-offer-new-form-genetherapy/?utm_source=mantis&utm_medium=recommend&utm_campaign=mantis
Reduced expression of brain cannabinoid receptor 1 (Cnr1) is coupled with an increased complementary micro-RNA (miR-26b) in a mouse model of fetal alcohol spectrum disorders (full–2014) http://www.clinicalepigeneticsjournal.com/content/5/1/14
Histone modifications are associated with Δ9-tetrahydrocannabinol-mediated alterations in antigen-specific T cell responses (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4081916/
Epigenetic Regulation of Genes that Modulate Chronic Stress-induced Visceral Pain in the Peripheral Nervous System (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25263804
Extravirgin olive oil up-regulates CB1 tumor suppressor gene in human colon cancer cells and in rat colon via epigenetic mechanisms (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25533906
Δ9 Tetrahydrocannabinol-mediated epigenetic modifications elicit myeloid-derived suppressor cell activation via STAT3/S100A8 (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/25713087
Epigenetic and Proteomic Expression Changes Promoted by Eating Addictive-like Behavior (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25944409
top


FAAH GENES +
More aroused, less fatigued: fatty acid amide hydrolase gene polymorphisms influence acute response to amphetamine (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2945903/
385 C/A polymorphism of the fatty acid amide hydrolase gene is associated with metabolic syndrome in the Chinese Han population (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3258756/
Adipose tissue endocannabinoid system gene expression: depot differences and effects of diet and exercise (full–2011) http://www.lipidworld.com/content/10/1/194
Association of genetic variation in cannabinoid mechanisms and gastric motor functions and satiation in overweight and obesity (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3117918/
The Endocannabinoid System as Pharmacological Target Derived from Its CNS Role in Energy Homeostasis and Reward. Applications in Eating Disorders and Addiction (link to PDF-2011) http://www.mdpi.com/1424-8247/4/8/1101
A polymorphism in the gene of the endocannabinoid-degrading enzyme FAAH (FAAH C385A) is associated with emotional–motivational reactivity (full–2012) http://link.springer.com/article/10.1007/s00213-012-2785-y/fulltext.html
Irritable Bowel Syndrome: Methods, Mechanisms, and Pathophysiology. Genetic epidemiology and pharmacogenetics in irritable bowel syndrome (full–2012) http://ajpgi.physiology.org/content/302/10/G1075
Randomized pharmacodynamic and pharmacogenetic trial of dronabinol effects on colon transit in irritable bowel syndrome-diarrhea (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3775711/
The genetic basis of the endocannabinoid system and drug addiction in humans (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/21937688
Investigation of endocannabinoid system genes suggests association between peroxisome proliferator activator receptor-α gene (PPARA) and schizophrenia (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22920733
Contribution of genetic variants to pain susceptibility in Parkinson disease (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22473870
Genetic variability in the endocannabinoid system and 12-week clinical response to citalopram treatment: the role of the CNR1, CNR2 and FAAH genes (abst–2012) http://jop.sagepub.com/content/26/10/1391
Contribution of genetic variants to pain susceptibility in Parkinson disease (abst–2012) http://onlinelibrary.wiley.com/doi/10.1002/j.1532-2149.2012.00134.x/abstract
Moderation of antipsychotic-induced weight gain by energy balance gene variants in the RUPP autism network risperidone studies (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693401/
FAAH selectively influences placebo effects (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4222079/
top
Impulsivity, Variation in the Cannabinoid Receptor (CNR1) and Fatty Acid Amide Hydrolase (FAAH) Genes, and Marijuana-Related Problems (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817049/
Evidence for a Common Endocannabinoid-Related Pathomechanism in Autism Spectrum Disorders (link to full–2013) http://www.sciencedirect.com/science/article/pii/S0896627313003619
No association of endocannabinoid genes with bipolar disorder or lithium response in a Sardinian sample (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24126189
Lack of association between C385A functional polymorphism of the fatty acid amide hydrolase gene and polycystic ovary syndrome (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23616186
Effects of C358A polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) on weight loss, adipocytokines levels, and insulin resistance after a high polyunsaturated fat diet in obese patients (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24445122
Association of the c.385C>A (p.Pro129Thr) polymorphism of the fatty acid amide hydrolase gene with anorexia nervosa in the Japanese population (full–2014) http://onlinelibrary.wiley.com/doi/10.1002/mgg3.69/full
Association of polymorphisms in the endocannabinoid system genes with myocardial infarction and plasma cholesterol levels (full–2014) http://biomed.papers.upol.cz/getrevsrc.php?identification=public&mag=bio&raid=825&type=fin&ver=3
Association of cannabinoid type 1 receptor and fatty acid amide hydrolase genetic polymorphisms in Chinese patients with irritable bowel syndrome (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24444427
Attenuation of Cystitis and Pain Sensation in Mice Lacking Fatty Acid Amide Hydrolase (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25374388
Defects in fatty acid amide hydrolase 2 in a male with neurologic and psychiatric symptoms (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423390/
Novel associations between FAAH genetic variants and postoperative central opioidrelated adverse effects (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25558980
FAAH genetic variation enhances fronto-amygdala function in mouse and human (full–2015) http://tinyurl.com/jphfuk5
Behavioral genetics: of mice, men, and internal bliss (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26035787
Gestation Related Gene Expression of the Endocannabinoid Pathway in Rat Placenta (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26229240
Pharmacogenetics in irritable bowel syndrome (full–2015) http://informahealthcare.com/doi/pdf/10.1517/17425255.2015.1048223
top


MAGL GENES
Mutation of Cys242 of Human Monoacylglycerol Lipase Disrupts Balanced Hydrolysis of 1- and 2-monoacylglycerols and Selectively Impairs Inhibitor (full–2013) http://molpharm.aspetjournals.org/content/early/2013/12/24/mol.113.090795.long
Increased tonic cannabinoid CB1R activity and brain region-specific desensitization of CB1R Gi/o signaling axis in mice with global genetic knockout of monoacylglycerol lipase (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26070239
Fever Is Mediated by Conversion of Endocannabinoid 2-Arachidonoylglycerol to Prostaglandin E2 (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26196692
Gestation Related Gene Expression of the Endocannabinoid Pathway in Rat Placenta (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26229240


MISC GENETICS +
The genetics of eating disorders (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21243475
Testing bidirectional effects between cannabis use and depressive symptoms: moderation by the serotonin transporter gene (abst–2011) http://onlinelibrary.wiley.com/doi/10.1111/j.1369-1600.2011.00380.x/abstract
The Interplay between Parental Monitoring and the Dopamine D4 Receptor Gene in Adolescent Cannabis Use (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3509099/pdf/pone.0049432.pdf
Sensation-seeking genes and physical activity in youth (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3581711/
A genetic perspective on the proposed inclusion of cannabis withdrawal in DSM-5 (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3733446/
Smoking Cannabis Increases Risk of Depression in the Case of Genetic Vulnerability, Study Finds (news–2012) http://www.sciencedaily.com/releases/2011/10/111010074853.htm
Implantation failure in mice with a disruption in Phospholipase C beta 1 gene: lack of embryonic attachment, aberrant steroid hormone signalling and defective endocannabinoid metabolism (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632219/
Testing bidirectional effects between cannabis use and depressive symptoms: moderation by the serotonin transporter gene (abst–2013) http://onlinelibrary.wiley.com/doi/10.1111/j.1369-1600.2011.00380.x/abstract
Mutations found in individuals with autism interfere with endocannabinoid signaling in the brain (news – 2013) http://medicalxpress.com/news/2013-04-mutations-individuals-autism-endocannabinoid-brain.html
Genetic Disruption of 2-Arachidonoylglycerol Synthesis Reveals a Key Role for Endocannabinoid Signaling in Anxiety Modulation (full–2014) http://www.cell.com/cell-reports/abstract/S2211-1247%2814%2900955-3?_returnURL=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS2211124714009553%3Fshowall%3Dtrue
top
Genetic predisposition to schizophrenia associated with increased use of cannabis (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382963/
Genetic dissection of the endocannabinoid system and how it changed our knowledge of cannabinoid pharmacology and mammalian physiology (abst–2014) http://onlinelibrary.wiley.com/doi/10.1002/9781118451281.ch4/summary
Heritability, SNP- and Gene-Based Analyses of Cannabis Use Initiation and Age at Onset (full–2015) http://link.springer.com/article/10.1007/s10519-015-9723-9/fulltext.html
Genotoxic properties of representatives of alkylindazoles and aminoalkyl-indoles which are consumed as synthetic cannabinoids (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25792264
Analysis of FABP4 expression pattern in rump fat deposition and metabolism of Altay sheep (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25665644
Association of single nucleotide polymorphisms in catechol-O-methyltransferase andserine-threonine protein kinase genes in the Pakistani schizophrenic population: a study with special emphasis on cannabis and smokeless tobacco (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25801838
Repeated forced swim stress differentially affects formalin-evoked nociceptive behaviour and the endocannabinoid system in stress normo-responsive and stress hyper-responsive rat strains (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25988529
Adolescent cannabis exposure interacts with mutant DISC1 to produce impaired adult emotional memory (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26093170
Impact of a synthetic cannabinoid (CP-47,497-C8) on protein expression in human cells: evidence for induction of inflammation and DNA damage (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26194647


RS GENES POLYMORPHISMS + (Various)
Cannabinoid receptor 1 gene polymorphisms and marijuana misuse interactions on white matter and cognitive deficits in schizophrenia (full–2011)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3085576/
Variants at the endocannabinoid receptor CB1 gene (CNR1) and insulin sensitivity, type 2 diabetes, and coronary heart disease (full–2011)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3686489/
The Endocannabinoid System as Pharmacological Target Derived from Its CNS Role in Energy Homeostasis and Reward. Applications in Eating Disorders and Addiction (link to PDF-2011) http://www.mdpi.com/1424-8247/4/8/1101
Functional polymorphism in the GPR55 gene is associated with anorexia nervosa (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/20506567
Association study of Cannabinoid receptor 1 (CNR1) gene in tardive dyskinesia (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21266946
Endocannabinoid type 1 receptor gene (CNR1) polymorphisms (rs806381, rs10485170, rs6454674, rs2023239) and cardiovascular risk factors in postmenopausal women (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21480765
top
Are endocannabinoid type 1 receptor gene (CNR1) polymorphisms associated with obesity and metabolic syndrome in postmenopausal Polish women? (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/20838400
Alelle specific differences in the activity of a novel cannabinoid receptor 1(CNR1) gene intronic enhancer in hypothalamus, dorsal root ganglia and hippocampus (full–2012) http://www.jbc.org/content/early/2012/02/23/jbc.M111.336750.long
Confirmation that the AKT1 (rs2494732) genotype influences the risk of psychosis in cannabis users (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22831980
Mutation of Cys242 of Human Monoacylglycerol Lipase Disrupts Balanced Hydrolysis of 1- and 2-monoacylglycerols and Selectively Impairs Inhibitor Potency (full–2013) http://molpharm.aspetjournals.org/content/early/2013/12/24/mol.113.090795.long
Testing bidirectional effects between cannabis use and depressive symptoms: moderation by the serotonin transporter gene (abst–2013) http://onlinelibrary.wiley.com/doi/10.1111/j.1369-1600.2011.00380.x/abstract
New Study: THC May Treat Inflammatory Diseases and Cancer By Altering Genes (news–2013) http://thejointblog.com/new-study-thc-may-treat-inflammatory-diseases-cancer-altering-genes/
Mutations found in individuals with autism interfere with endocannabinoid signaling in the brain (news–2013) http://medicalxpress.com/news/2013-04-mutations-individuals-autism-endocannabinoid-brain.html
Genetic polymorphism in pathogenesis of irritable bowel syndrome (full–2014) http://www.wjgnet.com/1007-9327/full/v20/i47/17693.htm
Genetic predisposition to schizophrenia associated with increased use of cannabis (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382963/
Role of CNR1 polymorphisms in moderating the effects of psychosocial adversity on impulsivity in adolescents (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24980155
Genetic dissection of the endocannabinoid system and how it changed our knowledge of cannabinoid pharmacology and mammalian physiology (abst–2014) http://onlinelibrary.wiley.com/doi/10.1002/9781118451281.ch4/summary
Genetic variability in the human cannabinoid receptor 1 is associated with resting state EEG theta power in humans (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25116250
Pharmacogenetics in irritable bowel syndrome (full–2015) http://informahealthcare.com/doi/pdf/10.1517/17425255.2015.1048223
top


cropped-sativa.jpg